Company: DERM
Filing Date: 2025-05-14
Form Type: 8-K
Source: 0001104659-25-048502
Chunk: 0

Company: Journey Medical Corp
Filing Date: 2025-05-14
Form: 8-K
Item: Item 2.02
Chunk 0
---
Item 2.02.

Results of Operations and Financial Condition.

On May 14, 2025, Journey
Medical Corporation issued a press release to provide a corporate update and to announce its financial results for the three months ended
March 31, 2025. A copy of such press release is being furnished as Exhibit 99.1 to this report.

The information, including
Exhibit 99.1, in this Form 8-K is being furnished and shall not be deemed “filed” for purposes of Section 18 of the Securities
Exchange Act of 1934, as amended, or otherwise subject to the liabilities of that Section. The information in this Form 8-K shall not
be incorporated by reference into any filing under the Securities Act of 1933, as amended, except as shall otherwise be expressly set
forth by specific reference in such filing.

Item 9.01. Financial Statements and Exhibits.

(d) Exhibits.

The following exhibits are furnished herewith:

  Exhibit      Description                                                                                            
   Number                                                                                                             
     99.1      Press release issued by Journey Medical Corporation, dated May 14, 2025.                               
 ──────────────────────────────────────────────────────────────────────────────────────────────────────────────────────
      104      Cover Page Interactive Data File, formatted in Inline Extensible Business Reporting Language (iXBRL).  

SIGNATURES

Pursuant to the requirements of the Securities
Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

  Journey Medical Corporation                                                       
  (Registrant)                                                                      
  By:                              /s/ Claude Maraoui                               
                                   Claude Maraoui                                   
                                   Chief Executive Officer, President and Director  

Date: May 14, 2025